Use of Psychedelics Show Correlation With Better Overall Physical Health
Do psychedelics improve health? A new study finds a correlation between user health and psychedelic experiences.
Jill Ettinger is a Los Angeles-based writer and editor immersed in digital publishing and storytelling with a focus on the global food and wellness systems and how they intersect with our cultural traditions, ethics, and politics. Her work has been featured in The Huffington Post, MTV, and the Village Voice.
Do psychedelics improve health? A new study finds a correlation between user health and psychedelic experiences.
Psychedelic use may help to decrease the risk of hypertension, according to new research.
Pharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy for treatment-resistant depression.
A new survey finds women are more likely to self-treat with psychedelics than men, particularly for issues including depression and trauma.
UK venture capital fund The Conscious Fund is working to make psychedelics more accessible and functional in various capacities.
The family of Bob Marley and Silo Wellness have teamed up for the first line of commercial psilocybin mushrooms.
This week in psychedelic business news, Canada expands legal distribution for psychedelics, therapeutic DMT stroke treatment, and more.
Numinus Biosciences has received expanded regulatory approval in Canada for psychedelic use and distribution.
The psychedelic drugs market is finding a strong base in North America, according to new data. The U.S. and Canada in particular are supporting its expansion.
Defiance has launched the world’s second psychedelics-focused ETF as investing in psychedelic therapy and treatment accelerates.
Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.